Impact of Subject Attrition on Sample Size Determinations for Longitudinal Cluster Randomized Clinical Trials

Author：

ISSN： 1054-3406

Source： Journal of Biopharmaceutical Statistics, Vol.24, Iss.3, 2014-05, pp. : 507-522

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Sample Size Determination for Three-Level Randomized Clinical Trials with Randomization at the First or Second Level

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 3, 2014-05 ,pp. : 579-599

Taylor & Francis Ltd

Access to resources Recommend Favorite

On Cost Effectiveness and Sample Size in Clinical Trials

By Augustinus A.M. Hart Marcel G.W. Dijkgraaf

PharmacoEconomics, Vol. 22, Iss. 10, 2004-01 ,pp. : 685-688

Adis International

Access to resources Recommend Favorite

Sample Size Determination for Testing Equality in a Cluster Randomized Trial with Noncompliance

By Lui Kung-Jong

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 1, 2011-01 ,pp. : 1-17

Taylor & Francis Ltd

Access to resources Recommend Favorite

Calculation of Tolerance Limits and Sample Size Determination for Clinical Trials with Dichotomous Outcomes

By Zaslavsky Boris G.

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 3, 2007-05 ,pp. : 481-491

Taylor & Francis Ltd

Access to resources Recommend Favorite

Sample Size Re-Estimation for Adaptive Sequential Design in Clinical Trials

By Gao Ping

Journal of Biopharmaceutical Statistics, Vol. 18, Iss. 6, 2008-11 ,pp. : 1184-1196

Taylor & Francis Ltd

Access to resources Recommend Favorite